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Introduction: Little is known about the effects of rehabilitation for 
patients with lung cancer after thoracotomy. The primary objective 
of this study was to evaluate the effect of a multidisciplinary reha-
bilitation program on quality of life (QOL) and secondary objectives 
were to determine its effects on pain and exercise capacity and the 
feasibility of combining rehabilitation with adjuvant chemotherapy.
Methods: Patients who had undergone a thoracotomy for lung 
cancer were randomized between rehabilitation and usual care. 
Rehabilitation consisted of twice-weekly training for 12 weeks start-
ing 1 month after hospital discharge, scheduled visits to pain special-
ists, and medical social work. QOL and pain were measured with 
validated questionnaires at baseline and after 1, 3, 6, and 12 months. 
Exercise tolerance was assessed at baseline and after 3 months with 
a 6-minute walking distance test.
Results: The study closed prematurely because of the introduction 
of video-assisted thoracoscopic surgery. Of 57 randomized patients, 
49 patients (23 active and 26 control) were analyzed. QOL was not 
significantly different between groups, although, the active group 
reported more pain after 3 and 6 months and more limitations because 
of physical problems after 3 months. In the active group, 6-minute 
walking distance improved by 35 m from preoperative baseline, as 
opposed to the control group that showed a decline by 59 m (p = 
0.024 for difference). Patients treated with adjuvant chemotherapy 
showed decreased attendance at training sessions.
Conclusion: Rehabilitation did not result in a better QOL. Exercise 
tolerance improved at the cost of more pain and more limitations 
because of physical problems. We suggest that rehabilitation is better 
postponed for 3 to 4 months after hospital discharge.
Key Words: Rehabilitation, Lung cancer, Thoracotomy, Quality of 
life, Exercise training.
(J Thorac Oncol. 2013;8: 214–221)
Although thoracoscopic surgery for lung cancer has been gaining ground rapidly over the last years, in many 
patients thoracotomy is still performed. Postoperative mor-
bidity after thoracotomy is characterized by a deterioration 
of existing preoperative impaired parameters, like physical, 
social, and mental state and thoracic pain.1 Decreased exercise 
tolerance is repeatedly described, particularly in patients after 
pneumonectomy measured after 3 to 6 months.2–4
Pain and a diminished exercise tolerance definitely influ-
ence daily activities and quality of life (QOL). A few studies 
demonstrated a decrease in QOL but a return to normal after 3 
to 6 months postoperatively.5–8
It has been shown that rehabilitation after coronary 
artery bypass surgery improves QOL and mortality and 
decreases the hospital admission rate.9 We surmised that a 
similar program of pulmonary rehabilitation could be 
beneficial for patients with lung cancer after thoracot-
omy. These patients share similarities with postoperative 
cardiac patients in characteristics such as health status and 
age, although pain is less of a problem after sternotomy 
compared with thoracotomy.
Literature on postthoracotomy rehabilitation is mini-
mal. Two nonrandomized trials in 10 and 25 patients showed 
improvements in exercise tolerance measured with 6-minute 
walking distance (6MWD) test after an 8- and 4-week reha-
bilitation program, respectively.10,11 The only randomized con-
trolled trial performed on 53 patients failed to demonstrate 
an effect of rehabilitation on exercise tolerance (6MWD) and 
QOL.12 This randomized study focused on physical param-
eters and QOL as outcome measures but special attention to 
pain management and psychosocial aspects was lacking. It 
seems obvious that optimization of pain treatment and psy-
chosocial care improves patients well-being and improves the 
circumstances for exercise training.
None of the studies reported on the feasibility of inte-
grating rehabilitation with adjuvant chemotherapy (ACT). 
Chemotherapy with subsequent toxicity may limit the pos-
sibilities of rehabilitation to a great extent, especially of an 
intensive training program.
For the current study, a multidisciplinary rehabilitation 
program was designed for postthoracotomy patients with 
resectable lung cancer. The program contained intensive 
exercise and muscle training, specialized pain treatment, and 
scheduled visits to a medical social worker.
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The primary objective of this randomized controlled 
trial was to evaluate the effect of this concise multidisciplinary 
rehabilitation program on QOL. Secondary objectives were to 
evaluate the effects of rehabilitation on exercise tolerance and 
pain sensation and also to explore the feasibility of a rehabili-
tation program in patients with ACT.
PATIENTS AND METHODS
Study Design and Patients
This study is a prospective parallel group randomized 
(1:1 ratio) controlled trial with 1-year follow-up carried out 
in the Isala Clinics, a large teaching hospital in Zwolle, The 
Netherlands. The design of the study is depicted in Fig. 1.
Resectable patients (aged 18–80 years) with non–small-
cell lung cancer were randomized before surgery to the active 
(rehabilitation) group or control (usual care) group. ACT was 
not an exclusion criterion and was administered according to 
national guidelines starting within 1 month after surgery.
Four weeks after discharge, active patients entered 
the 12-week rehabilitation program with exercise training 
by physiotherapists and scheduled visits to a specialized 
pain team and medical social worker.Twice a week, patients 
exercised between 60% and 80% of their peak cycling load 
(determined by a postoperative incremental cycling ergometer 
test) and performed muscle training. A dedicated anesthesi-
ologist adjusted pain treatment during the study according to 
the World Health Organization analgesic ladder.13 
Before discharge, patients consulted a medical social 
worker who assessed psychosocial problems and arranged a 
second visit during rehabilitation. In case of problems, direct 
help was provided or referral to a specialized facility was 
offered.
Patients in the control group received usual care 
consisting of routine outpatient appointments, scheduled 1, 
3, 6, and 12 months after discharge. Pain medication was 
prescribed by their pulmonologist or general practitioner. 
Referrals to physiotherapy or social work occurred on a 
personalized base.
The study was approved by the local medical ethics 
committee (NL14089.075.06). All patients provided written 
informed consent.
Assessments
Change in QOL was measured with the St. George’s 
respiratory questionnaire (SGRQ)14 before thoracotomy and 
1, 3, 6, and 12 months after discharge. During these time-
points, generic QOL was assessed with the Short Form health 
survey (SF-36),15 and pain with the Dutch version of the 
McGill Pain Questionnaire (MPQ-DLV)16 and use of analge-
sics was recorded.
Pulmonary function tests (PFT) and exercise capacity 
(6MWD) were measured before surgery and 3 months after 
discharge, corresponding to 2 months of exercise training. 
Attendance rates at planned rehabilitation sessions were 
determined to assess the feasibility of rehabilitation in patients 
with ACT.
Statistics
Sample size calculation was based on the SGRQ 
outcomes in a trial on chronic obstructive pulmonary diseases 
rehabilitation described by Rossi et al.17To demonstrate a 
two-sided (α = 0.05) difference between the study groups in 
mean change of the SGRQ total score of at least 4 (SD = 6.4) 
points (considered as the minimal clinically important 
difference)14,18 after 12 months, 44 patients are needed in each 
group (with a dropout rate of 10%).
After surgery, patients were randomized to the active 
(rehabilitation) group or control group, using a computer 
minimization system, initiated by the treating chest physi-
cian. The minimization program balanced patients for the 
following factors: age (< 70 or ≥ 70 years), sex (male or 
female), baseline 6MWD (< 100 m or ≥ 100 m), the forced 
expiratory volume in 1 second (FEV1) (FEV1< 40% 
or ≥ FEV1 40 %) and type of surgery (pneumonectomy versus 
other).
Primary analysis was based on an intention-to-treat. 
Differences between the two groups in mean change scores 
of the SGRQ total after 1, 3, 6, and 12 months were tested 
using analysis of covariance (ANCOVA). In contrast to the 
generally used t test, ANCOVA is able to control for baseline 
imbalances.19 ANCOVA was also used to test differences in 
MPQ-DLV, SF-36, 6MWD and PFT. The χ2 test was used to test 
differences in proportions from these assessments. Difference 
FIGURE 1.  Study design. NSCLC, non–small-cell lung cancer; R, randomization; 6MWD, 6-minute walking distance; QOL, 
quality of life; D, discharge from hospital.
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in attendance rate in the active group between patients with 
and without ACT was analyzed with Mann–Whitney U test.
p Values less than 0.05 were considered significant. 
Analyses were performed using SPSS-Statistics version 19.0 
(IBM corporation, Armonk, NY).
RESULTS
Patients
From May 2007 to September 2010, a total of 81 
patients were invited for participation. Sixty patients accepted 
the invitation and 57 were randomized.Twenty-seven patients 
were randomized to the active group and 30 to the control 
group. The reasons for the eight dropouts are shown in the 
consort flow chart (Fig. 2). This study was terminated pre-
maturely because of slow accrual as a result of the institution 
of video-assisted thoracoscopic surgery (VATS) by the end of 
2008.
Baseline characteristics (n = 49) are depicted in 
 Table 1. Ten of 23 patients in the active group, and six out of 
26 patients in the control group received ACT, but differences 
between both groups were not statistically significant.
Quality of Life
The primary endpoint of this study was the difference 
in SGRQ total score from baseline to 12 months and this was 
2.71(±6.90 SD) on a scale from 0 to 100 points (p = 0.69). 
(Fig. 3A). The SGRQ scores for the domains of symptoms, 
activity, and impact on daily life were not different between 
both groups.
The scores of the SF-36 domains of physical functioning, 
mental health, social functioning, role limitations because of 
emotional problems, and vitality were also not different in both 
groups after 3 months. The control group reported less role 
limitations because of physical problems at 3 months when 
compared with the active group (p = 0.03) (Fig. 3B). However, 
at 12 months, this difference disappeared. The scores of the 
general health in the active group seemed to be worse than in 
the control group at 3 and 6 months (p = 0.065 and p = 0.29, 
respectively [Fig. 3C]).
FIGURE 2.  Consort flow chart. 6MWD, 6-minute walking distance; QOL, quality of life.
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Finally, the quality of life index of the MPQ-DLV showed 
higher scores postoperatively, and as expected, improving in 
both groups over the observation period of 12 months. There 
were no significant differences between both groups at the 
evaluation points as illustrated in Figure 3D.
Exercise Tolerance
The rehabilitation program improved the 6MWD after 3 
months in the active group compared with the control group 
(mean difference between the groups adjusted for baseline 
characteristics was 94 ± 38 m [p = 0.024], Fig. 4). In the active 
group, only eight out of 23 patients performed a 6MWD at 3 
months of rehabilitation. The mean baseline 6MWD of these 
eight patients was comparable to the mean 6MWD measured 
at baseline in patients with baseline measurement only (524 
versus 519; p = 0.90). The 6MWD (mean SD) in the active 
group improved from 524 m (± 81) to 567 m (±78) (p = 0.037) 
(Table 2 and 3). In the active patients, 15 out of 23 did not 
perform a repeated 6MWD test because they dropped out or 
felt unable to perform the test. After 3 months of follow-up, 
the 6MWD in the control group decreased from 555 m (±113) 
to 491 m (±109) but this difference was not significant (p = 
0.079, Fig. 4). In the control group, 11 patients out of 25 per-
formed repeated 6MWD tests.
Only two out of 10 patients that were randomized to 
rehabilitation and received concurrent ACT performed a 
repeated 6MWD after 3 months. In the control group, a simi-
lar low rate of two out of six was observed in patients treated 
with ACT. Repeated 6MWD tests were available in six out of 
13 and nine out of 20 patients that did not have ACT, in the 
active and the control group, respectively.
Patients of both groups were asked during follow-up 
whether they had performed any physical training activities. 
The active group showed a gradual decline during 1st year of 
follow-up from 19 out of 21 (90%) after 1 month to 17 out 
of 21 (81%) after 3 months, and further down to nine out of 
16 (56%) after 1 year. However, the control group showed an 
initial low rate of physical training, one out of 27 (4%), which 
increased to a persistent one-third after 3 months.
Pulmonary Function Tests
The changes in PFT after thoracotomy were not signifi-
cantly different between the two groups (Table 1 and 2).
Pain
Patients in the active group reported significantly more 
pain (measured by the Visual Analogue Scale of the MPQ-
DLV) than the control group after 3 months (p = 0.042) and 
after 6 months (measured by the total pain rating index of the 
MPQ-DLV [p = 0.010]) as shown in Figure 5A and B.
In the pain-specific domain of the SF-36, active patients 
also reported more pain (p = 0.028) compared with controls 
after 3 months (Fig. 5C). The use of analgesics over time 
decreased significantly within subjects of both groups (p < 
0.001, not shown). The use of analgesics at 3 months was 
higher in the active group compared with controls (p = 0.048) 
as shown in Figure 5D.
Medical Social Work
Inpatient counselling (1 to 5 sessions per patient) by 
medical social work was provided for eight out of 23 patients 
(35%). Outpatient counselling (1 to 6 sessions per patient) 
was provided for four out of 23 patients (17%).
Compliance to Training Sessions
Only three out of 10 patients who were treated with 
ACT participated in the training program until week 12, as 
opposed to eight out of 13 of patients who did not receive ACT 
(Table 3). Attendance rates of patients treated with ACT and 
those without chemotherapy are given in Table 3.
DISCUSSION
This study is among the first to evaluate the effects of 
pulmonary rehabilitation for patients with resectable lung 
cancer after thoracotomy. To our knowledge, it was the first time 
that patients receiving ACT were also included. Although the 
primary end point of improvement of QOL was not observed, 
we observed significant improvements in exercise tolerance 
in patients receiving rehabilitation but also more perception 
of pain compared with the control group despite optimal pain 
control by a specialized team. In both groups study drop out 
rates were quite high indicating burdensome participation for 
many patients that was even more pronounced when ACTwas 
used. This was illustrated by the limited attendance to the 
training sessions in this subgroup. Therefore, rehabilitation 
should not be started before 3 or 4 months after a thoracotomy. 
TABLE 1.  Baseline Characteristics 
Active  
Group  
(n = 23)
Control  
Group  
(n = 26) p
Age (yr) 63.6 ± 10.2 63.2 ± 10.3 0.89
Sex male/female (%male) 21/2 (91%) 19/7 (73%) 0.15
Current smoker yes/no (%yes) 3/19 (13%) 6/19 (23%) 0.47
BMI (kg/m2) 26.1 ± 4.0 25.9 ± 3.5
FEV1 (L) 2.7 ± 0.6 2.5 ± 0.9 0.35
FEV1%predicted 84.7 ± 18.9 84.2 ± 23.3 0.94
IVC (L) 3.8 ± 1.0 3.7 ± 1.1 0.76
IVC %predicted 89.7 ± 21.9 94.8 ± 21.4 0.42
FEV1 %Vcmax 64.6 ± 10.0 63.4 ± 10.8 0.73
PEF (L/s) 8.1 ± 1.9 7.1 ± 2.3 0.13
6MWD (meter) 521 ± 95 510 ± 121 0.75
Adjuvant chemotherapy  
yes/no (%yes)
10/13 (44%) 6/20 (23%) 0.13
Surgery: 0.55
Lobectomy/bilobectomy 13 (57%) 16 (61%)
Pneumonectomy 9 (39%) 9 (35%)
VATS with minithoracotomy 1 (4%) 0
Wedge resection 0 1 (4%)
BMI, body mass index; FEV1, forced expiratory volume in 1 second; IVC, inspira-
tory vital capacity; PEF, peak flow; 6MWD, 6-minute walking distance. Data are mean 
and SD for the upper 11 variables.
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For cardiac rehabilitation, recommendations for starting 
such programs is generally 2 to 4 weeks after uncomplicated 
coronary and valvular procedures.20 Thoracotomy with 
spreading ribs and reduction of functional pulmonary tissue 
leads to more local morbidity than is usually expected after a 
sternotomy.
Quality of Life
Both groups in this study showed a slight but significant 
improvement in respiratory symptoms during the observation 
period but this did not result in improved QOL with rehabilita-
tion. Changes in generic QOL scores in both groups assessed 
by another test, SF-36, were similar for almost all domains. 
Both groups distinguished role limitations because of physi-
cal problems that were experienced more severely in patients 
in the active group at 3 months after discharge. Unfortunately, 
this part of the SF-36 questionnaire was completed by only 
a minority of patients because the questions were not appli-
cable to patients who were permanently disabled or retired. 
Our study failed to confirm the influence of rehabilitation on 
QOL and confirms the results of one previous study.12
FIGURE 3.  Quality of life and impact of pain on quality of life in resectable lung cancer patients treated in a postthoracotomy 
rehabilitation program (actives) or receiving usual care (controls). A, SGRQ. B, SF-36 role physical. C, SF-36 general health. 
D, MPQ-DLV QLI. SGRG, St. George’s Respiratory Questionnaire; SF-36, Short Form health survey; MPQ-DLV QLI, Dutch Version 
of the McGill Pain Questionnaire quality of life index; BD, before discharge. Error bars represent 95% confidence intervals.
FIGURE 4.  Exercise tolerance in patients treated in a pulmo-
nary rehabilitation program (actives) compared with usual 
care (controls) measured with the 6-minute walking distance, 
before and 3 months after discharge from hospital. Only the 
results of patients with a paired (preoperative/postoperative) 
6MWD test were used. 6-MWD, 6-minute walking distance. 
Error bars represent 95% confidence intervals.
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We observed an initial postoperative decline in general 
health, and physical and social functioning, and also observed 
an increased role of physical and emotional problems in both 
groups. All these domains did not restore the preoperative lev-
els after 12 months of follow-up. This is in contrast to reports 
in previous studies that showed recovering QOL (without 
rehabilitation) within 6 to 9 months.6–8
Exercise Tolerance
Patients did perform physically better with the rehabili-
tation program. After 2 months of exercise training there was 
an 8% improvement (94 m) in the 6MWD test. This improve-
ment seems modest, but it is an improvement compared with 
the preoperative level. Improvements of 6MWD tests after a 
rehabilitation program of 43% and 32%, reported in two small 
nonrandomized studies, were compared with baseline post-
operative values.10,11 There is one previous randomized trial 
studying the effect of rehabilitation after thoracotomy. The 
training program in that study (5-day postoperative inpatient 
training followed by nonsupervised training at home with 
home support) did not result in improved exercise tolerance as 
measured with the 6MWD.12
Compared with the training sessions in our rehabilitation 
program, the training intensity in both the nonrandomized 
studies was higher. Patients in the larger study followed 
an inpatient program of 3-hour sessions daily starting 
immediately after surgery and continuing for 1 month.11 The 
smaller nonrandomized study started later (between 2.5 and 
9.3 months, postoperatively), and the training sessions were 
also on a daily base.10 The exercise training in the randomized 
study was intensive in the immediate postoperative phase, but 
thereafter supervised training stopped, and exercise training 
proceeded to a home-based nonsupervised program.12 These 
patients were not trained on cycle ergometers and treadmills at 
predefined moderate to high levels (based on peak performance 
on incremental cycle ergometry) as was the case in our study. 
Supervision and training up to submaximal levels is probably 
necessary to improve exercise tolerance in these patients as we 
demonstrated in our study.
Pain
Patients in both groups experienced a decrease in pain 
over time, in the observation period, but the active patients 
reported significantly more pain after 3 and 6 months, despite 
the intensified pain treatment reflected by higher use of anal-
gesics. All patients were treated similarly with epidural anal-
gesics immediately postoperation and therefore, acute pain 
scores showed no differences before hospital discharge. The 
similar pain scores of both groups, 1 month after discharge, 
was not surprising because it coincided with the first out-
patient contact of the active group with the specialized pain 
team. Until that moment patients had a comparable treatment 
provided by pulmonologists and general practitioners. From 
that visit on, patients in the active group started exercise train-
ing under optimized pain treatment and monitoring. Perhaps, 
the intensive physical training program had detrimental effects 
on pain by constantly stretching the painful thoracic cage and 
fresh scars.
Prescheduled visits to a specialized pain-treating 
anesthesiologist as an elementary component of the study 
protocol was absent in all former studies. Information on 
the course and intensity of pain during postthoracotomy 
rehabilitation is minimal in those studies.10,11 One randomized 
study measured pain as part of a QOL questionnaire but did 
not find a difference in perception of pain between the active 
and control group.12 However, in those studies, as opposed to 
our study, exercise training was nonsupervised and the level 
of exercise was not defined; therefore, patients might have 
performed their exercise training at lower levels than our 
patients.
Remarkably, the impact of pain on QOL did not differ in 
both groups in our study. It is likely that rehabilitating patients 
accept some amount of pain as part of their recovery.
Adjuvant Chemotherapy
We demonstrated that ACTand exercise sessions were 
hard to combine. Patients treated with ACT had higher rates 
TABLE 3.  Dropout Numbers and Attendance Rates in 
Relation to the Use of Adjuvant Chemotherapy in the Active 
Group (n = 21) 
Adjuvant Chemotherapy
Yes No
No. of Patients No. of Patients p
Randomized to traininga 9 12
Completed training 3  8 0.20
Attendance rate (mean) 43% ±31 62% ±37   0.15b
Attendance rate (median) 33% 83% 0.39
aOne patient with ACT and one patient without ACT did not attend at all. Of the 
two patients, one treated with ACT and one not treated with ACT. No data regarding 
attendance was available.
bMann–Whitney U test.
TABLE 2.  Changes in Lung Function and 6MWD from Baseline and at 3 Months Adjusted for Baseline Value 
Active Group (n = 9) Control Group (n = 14) Mean Difference (A–C) p
FEV1 (L) −0.44 ± 0.14 −0.58 ± 0.11 0.15 ± 0.8 0.42
FEV1 %predicted −15.0 ± 4.7 −17.8 ± 3.8 2.8 ± 6.1 0.65
IVC (L) −0.21 ± 0.25 (n = 8) −0.77 ± 0.19 0.56 ± 0.32 0.093
IVC %predicted −7.3 ± 6.3 (n = 8) −18.8 ± 4.7 11.5 ± 8.1 0.17
6MWD (m) 35 ± 29 (n = 8) −59 ± 24 (n=11) 94 ± 38 0.024
Mean ± SE.
FEV1, forced expiratory volume in 1 second; IVC, inspiratory vital capacity; PEF, peak flow; 6MWD, 6-minute walking distance.
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of nonattendance at training sessions and resigned more 
often from further training than the controls did. The very 
low number of repeated 6MWD tests in the active group also 
reflected the high dropout rate in the subgroup of patients 
receiving ACT.
Video-Assisted Thoracoscopic Surgery
Inclusion of patients in this study was terminated 
prematurely before the planned number was reached. This 
was caused by the introduction of VATS by the end of 2008. 
The majority of patients from then on were operated by this 
approach and accrual decreased. For patients suffering less 
acute pain after VATS, rehabilitation and particularly physical 
exercise training was more likely to be feasible. Furthermore, 
VATS is relatively more often applied in smaller tumors 
requiring no ACT. Further studies on immediate postopera-
tive rehabilitation should be performed in a more homog-
enous group suffering less pain and not treated with ACT, for 
instance in patients with lower stages of lung cancer treated 
with VATS.
Limitations
We expected to find an improvement of respiratory 
symptoms and QOL with rehabilitation analogous to the 
results of rehabilitation for patients with chronic obstruc-
tive lung diseases. The tool we used to measure improve-
ments in QOL (SGRQ) was developed for patients with 
chronic obstructive pulmonary diseases. Premature closure of 
the study resulted in a lower number of patients than origi-
nally calculated, thereby decreasing the power of the study. 
Furthermore, there were many dropouts caused by premature 
termination of participation particularly because of pain, and 
the burden of ACT, and its toxicity. Nevertheless, we do con-
sider our study population as representative of the majority 
of patients receiving lung cancer surgery in community hos-
pitals, and patient selection was diminished by preoperative 
FIGURE 5.  Sensation of pain and use of analgesics in resectable lung cancer patients treated in a postthoracotomy  
rehabilitation program (actives) or receiving usual care (controls). A, MPQ-DLV PRI total. B, MPQ-DLV VAS present. C, SF-36 
pain. D, use of analgesics. MPQ-DLV PRI total, total pain rating index of the Dutch version of the McGill Pain Questionnaire; 
MPQ-DLV VAS, Dutch version of the McGill Pain Questionnaire Visual Analogue Scale; SF-36, Short Form health survey;  
BS, before surgery; BD, before discharge. Error bars represent 95% confidence intervals.
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randomization. Despite serious limitations, significant differ-
ences were observed between study groups regarding exercise 
tolerance, pain sensation, and QOL.
CONCLUSION
The multidisciplinary rehabilitation program assessed 
in this study did not result in improved disease-specific QOL 
after thoracotomy. Rehabilitating patients experienced more 
physical limitations compared with controls at 3 months 
because of early start of rehabilitation after thoracotomy, 
especially in ACT patients. However, we observed a signifi-
cant improvement of exercise tolerance in the active group 
3 months after discharge. This benefit was at the expense of 
significant more pain despite programmed pain management 
by experienced specialists. An accelerated return to higher 
exercise levels without improving QOL does not outweigh 
increased and prolonged pain sensation. We suggest start-
ing rehabilitation programs for patients with lung cancer not 
before 3 to 4 months after thoracotomy.
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